Alps Advisors Inc. Sells 65,442 Shares of Marsh & McLennan Companies, Inc. $MRSH

Key Points

• Alps Advisors cut its Marsh & McLennan stake by 60.1%, selling 65,442 shares in the third quarter; it retained 43,362 shares valued at about $7.4 million.
• Marsh & McLennan reported quarterly EPS of $2.03, beating the $1.96 consensus estimate, while revenue rose 8.1% year over year to $6.86 billion.
• The company declared a quarterly dividend of $0.99 per share, equivalent to a 1.9% annualized yield. Analysts’ average rating was Hold, with an average price target of $205.84.

Alps Advisors Inc. reduced its holdings in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) by 60.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 43,362 shares of the financial services provider's stock after selling 65,442 shares during the quarter. Alps Advisors Inc.'s holdings in Marsh & McLennan Companies were worth $7,403,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in MRSH. Asset Dedication LLC acquired a new position in Marsh & McLennan Companies during the first quarter worth approximately $25,000. Quest 10 Wealth Builders Inc. grew its stake in shares of Marsh & McLennan Companies by 95.0% during the 3rd quarter. Quest 10 Wealth Builders Inc. now owns 156 shares of the financial services provider's stock valued at $27,000 after buying an additional 76 shares during the period. EFG International AG acquired a new stake in shares of Marsh & McLennan Companies during the 2nd quarter worth $30,000. Bell Investment Advisors Inc acquired a new stake in shares of Marsh & McLennan Companies during the 2nd quarter worth $31,000. Finally, Trifecta Capital Advisors LLC purchased a new position in shares of Marsh & McLennan Companies in the 2nd quarter worth $34,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.

Marsh & McLennan Companies Stock Down 2.5%

NYSE MRSH opened at $204.29 on Friday. The stock has a market cap of $97.14 billion, a PE ratio of 24.44, a PEG ratio of 2.77 and a beta of 0.53. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $214.00. The business has a 50 day moving average of $183.78. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.09 and a current ratio of 1.09.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last issued its quarterly earnings data on Thursday, October 15th. The financial services provider reported $2.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.96 by $0.07. Marsh & McLennan Companies had a net margin of 14.20% and a return on equity of 33.32%. The company had revenue of $6.86 billion during the quarter. The firm's revenue for the quarter was up 8.1% compared to the same quarter last year. Sell-side analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.49 EPS for the current fiscal year.

Marsh & McLennan Companies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Thursday, October 1st will be issued a $0.99 dividend. The ex-dividend date is Thursday, October 1st. This represents a $3.96 dividend on an annualized basis and a yield of 1.9%. Marsh & McLennan Companies's payout ratio is currently 47.37%.

Insiders Place Their Bets

In other news, VP Stacy Mills sold 1,215 shares of Marsh & McLennan Companies stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $200.00, for a total transaction of $243,000.00. Following the sale, the vice president directly owned 2,705 shares of the company's stock, valued at approximately $541,000. The trade was a 30.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Dean Klisura sold 4,194 shares of the business's stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $200.00, for a total value of $838,800.00. Following the completion of the transaction, the chief executive officer owned 20,935 shares in the company, valued at approximately $4,187,000. This trade represents a 16.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company's stock.

Marsh & McLennan Companies News Roundup

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $11.39 from $11.23 and FY2028 to $12.28 from $12.13. It also nudged several quarterly forecasts higher. These revisions point to improving expectations for earnings growth, though they are one research firm’s estimates.
• Positive Sentiment: BMO Capital Markets raised MRSH to Outperform, a favorable analyst rating that may bolster investor sentiment. Read article: Marsh & McLennan Companies Raised to Outperform at BMO Capital Markets
• Positive Sentiment: A published valuation analysis says MRSH may be 27% undervalued following the AltamarCAM deal, suggesting potential upside if investors agree with its assessment. Read article: Marsh Stock May Be 27% Undervalued Following AltamarCAM Deal
• Neutral Sentiment: Marsh appointed Marcus Baker chairman and Michael Walls global head of Marine, Cargo, and Logistics. The leadership changes may be relevant to the business, but the report provides no financial details indicating an immediate earnings impact. Read article: Marsh & McLennan appoints Marcus Baker and Michael Walls
• Negative Sentiment: Zacks lowered its Q4 2026 EPS estimate to $2.15 from $2.19 and Q3 2027 to $2.19 from $2.21. Its FY2026 estimate of $10.43 also remains below the cited consensus of $10.48, indicating some near-term caution.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on MRSH shares. Weiss Ratings restated a "hold (c)" rating on shares of Marsh & McLennan Companies in a report on Wednesday. Cantor Fitzgerald boosted their target price on Marsh & McLennan Companies from $212.00 to $218.00 and gave the stock an "overweight" rating in a report on Tuesday, July 21st. UBS Group increased their target price on shares of Marsh & McLennan Companies from $216.00 to $222.00 and gave the stock a "buy" rating in a research report on Tuesday, October 6th. Citigroup raised their price target on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a "neutral" rating in a report on Friday, October 16th. Finally, The Goldman Sachs Group cut their price target on shares of Marsh & McLennan Companies from $197.00 to $191.00 and set a "neutral" rating on the stock in a report on Thursday, October 1st. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $205.84.

About Marsh & McLennan Companies

Marsh & McLennan Companies, now known as Marsh, is a professional services firm focused on risk, strategy and people. Its businesses help organizations assess and manage risk, arrange insurance and reinsurance, and address workforce and organizational challenges.

The company operates through Marsh, an insurance brokerage and risk advisory business; Guy Carpenter, which specializes in reinsurance and related risk services; Mercer, which provides health, wealth and career consulting; and Oliver Wyman, a management consulting firm.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.